Veterinary PoC Diagnostics Industry - Major Leaders & Their Dominance in the Global Industry

Overview of This Study:

The study involved four major activities in estimating the size of the global veterinary point-of-care diagnostics market. Exhaustive secondary research was done to collect information on the adoption of different technologies and their regional adoption trends. Industry experts further validated the data obtained through secondary research through primary research.

Furthermore, the market size estimates and forecast provided in this study are derived through a mix of the bottom-up approach (country-level incidence data for various diseases) and top-down approach (assessment of utilization/adoption/penetration trends, by product, technology, application, animal type, and end user). After that, market breakdown and data triangulation methods were used to estimate the market size of segments and subsegments.

Major Growth Driving Factors:

Factors such as increasing prevalence of zoonotic diseases among companion and livestock animals and the growing need for the rapid detection of these diseases, along with the advantages of POCT over laboratory analysis are driving the growth of this market during the forecast period. However, the high cost of veterinary imaging instruments is restraining the growth of this market to some extent.

Find More Details - Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105329994

Global Leading Companies:

Some of the other prominent players operating in the veterinary point-of-care diagnostics market are Heska Corporation (US), Virbac (France), Thermo Fisher Scientific, Inc. (US), Eurolyser Diagnostica GmbH (Austria), Woodley Equipment Company (UK), Randox Laboratories LTD. (UK), AniPOC, Ltd. (UK), Carestream Health, Inc. (a part of ONEX Corporation) (Canada), NeuroLogica Corporation (a part of Samsung Electronics Co. Ltd.) (South Korea), and FUJIFILM SonoSite (a part of FUJIFILM Holdings Corporation) (Japan).

Zoetis, Inc. (US) dominated the global veterinary point-of-care diagnostics market 2018. The company has a diversified product portfolio, which includes a wide range of point-of-care diagnostic products. IDEXX’s position in the market is attributed to its active R&D activities and wide distribution footprint across the world. To garner a larger share of the market, the company continuously focuses on product developments and launches.

IDEXX Laboratories, Inc. (US) accounted for the second-largest share of the veterinary point-of-care diagnostics market in 2018. Its dominance in the market can be attributed to its wide range of product offerings and its strong geographical footprint. In 2018, the company acquired Abaxis, Inc. (US), a pioneer in the veterinary point-of-care diagnostics industry for USD 2.0 billion. The company also focuses on R&D activities to develop its animal health solutions that meet the customers’ demands.

Recent Developments by Leading Companies:

# In 2019, IDEXX Laboratories launched a Canine Progesterone Test for Catalyst Dx and Catalyst One Chemistry Analyzers.

# In 2019, Zoetis, Inc. launched Stablelab, a handheld point-of-care diagnostic blood test for equine.

# In 2019, FUJIFILM SonoSite partnered with Partners Healthcare (US) to enable clinicians to perform scans at point of care.

# In 2019, Eurolyser partnered with Sysmex Corporation (Japan) to sell Eurolyser’s point of care systems measuring CRP.

Request to Get the Customized Information@
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=105329994

Geographical Growth Scenario:

North America will continue to dominate the market during the forecast period

The market, by region, is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the veterinary point-of-care diagnostics market in 2018. The large share of North America in the global market can be attributed to the increasing adoption of companion animals, growing veterinary healthcare expenditure, and rising demand for animal-derived food products.

Veterinary PoC Diagnostics Market worth $2.4 billion by 2025 - Exclusive Report by MarketsandMarkets™

 The global Veterinary PoC Diagnostics Market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of 8.9%, according to a new report by MarketsandMarkets™. Growth in the companion animal population, rising demand for pet insurance, increasing number of veterinary practitioners in developed economies, and technological advancements are some of the factors driving the growth of this market during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105329994

Browse in-depth TOC on "Veterinary PoC Diagnostics Market”
282 – Tables
40 – Figures
262 – Pages

In 2018, the consumables segment dominated the veterinary point-of-care diagnostics market

Based on the product, the consumables segment accounted for the largest share of the veterinary point-of-care diagnostics market in 2019. The increasing volume of clinical chemistry tests performed globally, due to the rising prevalence of chronic diseases in animals, has triggered the development of consumables.

By technology, the clinical biochemistry segment accounted for the largest share of the veterinary point-of-care diagnostic kits and analyzers market in 2018

Based on technology, the market is segmented into immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, urinalysis, and other technologies. In 2018, the clinical biochemistry segment accounted for the largest share of the veterinary point-of-care diagnostic kits and analyzers industry. The higher preference for various advanced clinical diagnostic products by veterinarians and pet owners are contributing to the large share of this segment.

By application, the clinical pathology segment accounted for the largest market share in 2018

Based on application, the veterinary point-of-care diagnostics market is segmented into clinical pathology, bacteriology, virology, parasitology, and other applications. The clinical pathology segment accounted for the largest market share in 2018. This segment is also projected to register the highest CAGR during the forecast period. The growth in this segment can be attributed to the increasing adoption of chemistry analyzers for the primary diagnosis of diseases in clinics.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=105329994

By animal type, the companion animals segment accounted for the largest share of the veterinary point-of-care diagnostics market in 2018

Based on animal type, the market is segmented into companion and livestock animals. In 2018, the companion animals segment accounted for the largest share of the veterinary point-of-care diagnostics market. The increasing companion animal ownership, growing awareness about animal health among pet owners, and rising pet healthcare expenditure are some the factors stimulating the growth of this segment.

By end user, the veterinary clinics segment accounted for the largest share of the veterinary point-of-care diagnostics market in 2018

Based on end user, the market is segmented into veterinary hospitals & academic institutes, veterinary clinics, and home care settings. In 2018, the veterinary clinics segment accounted for the largest share of the market. The large share of this segment is attributed to the growing number of patients visiting vet clinics and the increasing number of private clinical practices.

Prominent players in the veterinary point-of-care diagnostics market include Zoetis, Inc. (US), IDEXX Laboratories, Inc. (US), Heska Corporation (US), Virbac (France), Thermo Fisher Scientific, Inc. (US), Eurolyser Diagnostica GmbH (Austria), Woodley Equipment Company (UK), Randox Laboratories LTD. (UK), AniPOC, Ltd. (UK), Carestream Health, Inc. (a part of ONEX Corporation) (Canada), NeuroLogica Corporation (a part of Samsung Electronics Co. Ltd.) (South Korea), and FUJIFILM SonoSite (a part of FUJIFILM Holdings Corporation) (Japan).

Get 10% Free Customization on this Report: 
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=105329994

Browse Adjacent Market: Medical Devices Market Research Reports & Consulting

Related Reports:

Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) - Global Forecast to 2026
https://www.marketsandmarkets.com/Market-Reports/point-of-care-molecular-diagnostic-market-143524127.html

Veterinary PoC Diagnostics Market worth $2.4 billion by 2025

 Overview:

The study involved four major activities in estimating the size of the global veterinary point-of-care diagnostics market. Exhaustive secondary research was done to collect information on the adoption of different technologies and their regional adoption trends. Industry experts further validated the data obtained through secondary research through primary research.

Furthermore, the market size estimates and forecast provided in this study are derived through a mix of the bottom-up approach (country-level incidence data for various diseases) and top-down approach (assessment of utilization/adoption/penetration trends, by product, technology, application, animal type, and end user). After that, market breakdown and data triangulation methods were used to estimate the market size of segments and subsegments.

Recent Developments:

# In 2019, IDEXX Laboratories launched a Canine Progesterone Test for Catalyst Dx and Catalyst One Chemistry Analyzers.

# In 2019, Zoetis, Inc. launched Stablelab, a handheld point-of-care diagnostic blood test for equine.

# In 2019, FUJIFILM SonoSite partnered with Partners Healthcare (US) to enable clinicians to perform scans at point of care.

# In 2019, Eurolyser partnered with Sysmex Corporation (Japan) to sell Eurolyser’s point of care systems measuring CRP.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105329994

Expected Revenue Surge:

The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of 8.9%.

Growth Boosting Factors:

Growth in the companion animal population, rising demand for pet insurance, increasing number of veterinary practitioners in developed economies, and technological advancements are some of the factors driving the growth of this market during the forecast period.

Key Questions Addressed in the Report:

# Who are the top 10 players operating in the global veterinary point-of-care diagnostics market?
# What covers the drivers, restraints, opportunities, and challenges in the veterinary point-of-care diagnostics industry?
# What are the new technological advancements in the veterinary point-of-care diagnostics market?
# Comment on the regulatory scenario for the veterinary point-of-care diagnostics industry in various geographies.
# What are the growth trends in the veterinary point-of-care diagnostics market at the segmental and overall market levels?

Data Triangulation:

After arriving at the overall veterinary point-of-care diagnostics market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

By end user, the veterinary clinics segment accounted for the largest share of the veterinary point-of-care diagnostics market in 2018

Based on end user, the market is segmented into veterinary hospitals & academic institutes, veterinary clinics, and home care settings. In 2018, the veterinary clinics segment accounted for the largest share of the market. The large share of this segment is attributed to the growing number of patients visiting vet clinics and the increasing number of private clinical practices.

Key Players:

Prominent players in the veterinary point-of-care diagnostics market include Zoetis, Inc. (US), IDEXX Laboratories, Inc. (US), Heska Corporation (US), Virbac (France), Thermo Fisher Scientific, Inc. (US), Eurolyser Diagnostica GmbH (Austria), Woodley Equipment Company (UK), Randox Laboratories LTD. (UK), AniPOC, Ltd. (UK), Carestream Health, Inc. (a part of ONEX Corporation) (Canada), NeuroLogica Corporation (a part of Samsung Electronics Co. Ltd.) (South Korea), and FUJIFILM SonoSite (a part of FUJIFILM Holdings Corporation) (Japan).

North America will continue to dominate the market during the forecast period

The market, by region, is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the veterinary point-of-care diagnostics market in 2018. The large share of North America in the global market can be attributed to the increasing adoption of companion animals, growing veterinary healthcare expenditure, and rising demand for animal-derived food products.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=105329994

Veterinary PoC Diagnostics Market worth $2.4 billion by 2025

 Overview:

The study involved four major activities in estimating the size of the global veterinary point-of-care diagnostics market. Exhaustive secondary research was done to collect information on the adoption of different technologies and their regional adoption trends. Industry experts further validated the data obtained through secondary research through primary research.

Furthermore, the market size estimates and forecast provided in this study are derived through a mix of the bottom-up approach (country-level incidence data for various diseases) and top-down approach (assessment of utilization/adoption/penetration trends, by product, technology, application, animal type, and end user). After that, market breakdown and data triangulation methods were used to estimate the market size of segments and subsegments.

Revenue Growth Projections:

The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of 8.9%.

Major Growth Boosting Factors:

Factors such as increasing prevalence of zoonotic diseases among companion and livestock animals and the growing need for the rapid detection of these diseases, along with the advantages of POCT over laboratory analysis are driving the growth of this market during the forecast period. However, the high cost of veterinary imaging instruments is restraining the growth of this market to some extent.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105329994

In 2018, the consumables segment dominated the veterinary point-of-care diagnostics market

Based on the product, the consumables segment accounted for the largest share of the veterinary point-of-care diagnostics market in 2019. The increasing volume of clinical chemistry tests performed globally, due to the rising prevalence of chronic diseases in animals, has triggered the development of consumables.

By technology, the clinical biochemistry segment accounted for the largest share of the veterinary point-of-care diagnostic kits and analyzers market in 2018

Based on technology, the market is segmented into immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, urinalysis, and other technologies. In 2018, the clinical biochemistry segment accounted for the largest share of the veterinary point-of-care diagnostic kits and analyzers industry. The higher preference for various advanced clinical diagnostic products by veterinarians and pet owners are contributing to the large share of this segment.

By application, the clinical pathology segment accounted for the largest market share in 2018

Based on application, the veterinary point-of-care diagnostics market is segmented into clinical pathology, bacteriology, virology, parasitology, and other applications. The clinical pathology segment accounted for the largest market share in 2018. This segment is also projected to register the highest CAGR during the forecast period. The growth in this segment can be attributed to the increasing adoption of chemistry analyzers for the primary diagnosis of diseases in clinics.

By animal type, the companion animals segment accounted for the largest share of the veterinary point-of-care diagnostics market in 2018

Based on animal type, the market is segmented into companion and livestock animals. In 2018, the companion animals segment accounted for the largest share of the veterinary point-of-care diagnostics market. The increasing companion animal ownership, growing awareness about animal health among pet owners, and rising pet healthcare expenditure are some the factors stimulating the growth of this segment.

By end user, the veterinary clinics segment accounted for the largest share of the veterinary point-of-care diagnostics market in 2018

Based on end user, the market is segmented into veterinary hospitals & academic institutes, veterinary clinics, and home care settings. In 2018, the veterinary clinics segment accounted for the largest share of the market. The large share of this segment is attributed to the growing number of patients visiting vet clinics and the increasing number of private clinical practices.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=105329994

Global Key Players:

Prominent players in the veterinary point-of-care diagnostics market include Zoetis, Inc. (US), IDEXX Laboratories, Inc. (US), Heska Corporation (US), Virbac (France), Thermo Fisher Scientific, Inc. (US), Eurolyser Diagnostica GmbH (Austria), Woodley Equipment Company (UK), Randox Laboratories LTD. (UK), AniPOC, Ltd. (UK), Carestream Health, Inc. (a part of ONEX Corporation) (Canada), NeuroLogica Corporation (a part of Samsung Electronics Co. Ltd.) (South Korea), and FUJIFILM SonoSite (a part of FUJIFILM Holdings Corporation) (Japan).

Veterinary PoC Diagnostics Market worth $2.4 billion by 2025

 Overview:

The study involved four major activities in estimating the size of the global veterinary point-of-care diagnostics market. Exhaustive secondary research was done to collect information on the adoption of different technologies and their regional adoption trends. Industry experts further validated the data obtained through secondary research through primary research.

Furthermore, the market size estimates and forecast provided in this study are derived through a mix of the bottom-up approach (country-level incidence data for various diseases) and top-down approach (assessment of utilization/adoption/penetration trends, by product, technology, application, animal type, and end user). After that, market breakdown and data triangulation methods were used to estimate the market size of segments and subsegments.

Expected Revenue Surge:

The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of 8.9%.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105329994

Major Growth Boosting Factors:

Factors such as increasing prevalence of zoonotic diseases among companion and livestock animals and the growing need for the rapid detection of these diseases, along with the advantages of POCT over laboratory analysis are driving the growth of this market during the forecast period. However, the high cost of veterinary imaging instruments is restraining the growth of this market to some extent.

Global Industry Segmentation:

The veterinary point-of-care diagnostics market is segmented based on product, technology, application, end user, and animal type.

In 2018, the consumables segment dominated the veterinary point-of-care diagnostics market

Based on the product, the consumables segment accounted for the largest share of the veterinary point-of-care diagnostics market in 2019. The increasing volume of clinical chemistry tests performed globally, due to the rising prevalence of chronic diseases in animals, has triggered the development of consumables.

By technology, the clinical biochemistry segment accounted for the largest share of the veterinary point-of-care diagnostic kits and analyzers market in 2018

Based on technology, the market is segmented into immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, urinalysis, and other technologies. In 2018, the clinical biochemistry segment accounted for the largest share of the veterinary point-of-care diagnostic kits and analyzers industry. The higher preference for various advanced clinical diagnostic products by veterinarians and pet owners are contributing to the large share of this segment.

By application, the clinical pathology segment accounted for the largest market share in 2018

Based on application, the veterinary point-of-care diagnostics market is segmented into clinical pathology, bacteriology, virology, parasitology, and other applications. The clinical pathology segment accounted for the largest market share in 2018. This segment is also projected to register the highest CAGR during the forecast period. The growth in this segment can be attributed to the increasing adoption of chemistry analyzers for the primary diagnosis of diseases in clinics.

By animal type, the companion animals segment accounted for the largest share of the veterinary point-of-care diagnostics market in 2018

Based on animal type, the market is segmented into companion and livestock animals. In 2018, the companion animals segment accounted for the largest share of the veterinary point-of-care diagnostics market. The increasing companion animal ownership, growing awareness about animal health among pet owners, and rising pet healthcare expenditure are some the factors stimulating the growth of this segment.

By end user, the veterinary clinics segment accounted for the largest share of the veterinary point-of-care diagnostics market in 2018
Based on end user, the market is segmented into veterinary hospitals & academic institutes, veterinary clinics, and home care settings. In 2018, the veterinary clinics segment accounted for the largest share of the market. The large share of this segment is attributed to the growing number of patients visiting vet clinics and the increasing number of private clinical practices.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=105329994

Key Players:

Prominent players in the veterinary point-of-care diagnostics market include Zoetis, Inc. (US), IDEXX Laboratories, Inc. (US), Heska Corporation (US), Virbac (France), Thermo Fisher Scientific, Inc. (US), Eurolyser Diagnostica GmbH (Austria), Woodley Equipment Company (UK), Randox Laboratories LTD. (UK), AniPOC, Ltd. (UK), Carestream Health, Inc. (a part of ONEX Corporation) (Canada), NeuroLogica Corporation (a part of Samsung Electronics Co. Ltd.) (South Korea), and FUJIFILM SonoSite (a part of FUJIFILM Holdings Corporation) (Japan).

Veterinary PoC Diagnostics Market - Growing Demand for Pet Insurance & Increasing Pet Care Expenditure

Market Size Estimation:

The total market size for the veterinary point-of-care diagnostics market was arrived at after data triangulation from three different approaches, as mentioned below.

Approach to calculate revenue of different players in the veterinary point-of-care diagnostics market

In this report, the revenue of individual companies were gathered from public sources and databases. In certain cases, the share of veterinary point-of-care diagnostics business for kits & analyzers was ascertained after a detailed analysis of various parameters, including product portfolio, market positioning, selling price, and geographic reach & strength, among others. Individual shares or estimates were validated through expert interviews.

Approach to calculate parent markets of the veterinary point-of-care diagnostics market

In this report, the veterinary companion animal diagnostics market, veterinary radiography systems market, veterinary ultrasound imaging systems market, veterinary CT scanners market, and veterinary imaging market from MnM’s repository were referred to in order to obtain the market size of the veterinary point-of-care diagnostics market. A weighted average of numbers obtained from these reports was taken to derive the market size of the global veterinary point-of-care diagnostics market.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105329994

Expected Revenue Growth:

The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of 8.9%.

Major Growth Boosting Factors:

Factors such as increasing prevalence of zoonotic diseases among companion and livestock animals and the growing need for the rapid detection of these diseases, along with the advantages of POCT over laboratory analysis are driving the growth of this market during the forecast period. However, the high cost of veterinary imaging instruments is restraining the growth of this market to some extent.

By technology, the clinical biochemistry segment accounted for the largest share of the veterinary point-of-care diagnostic kits and analyzers market in 2018

Based on technology, the market is segmented into immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, urinalysis, and other technologies. In 2018, the clinical biochemistry segment accounted for the largest share of the veterinary point-of-care diagnostic kits and analyzers industry. The higher preference for various advanced clinical diagnostic products by veterinarians and pet owners are contributing to the large share of this segment.

Geographical Growth Survey:

North America will continue to dominate the market during the forecast period

The market, by region, is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the veterinary point-of-care diagnostics market in 2018. The large share of North America in the global market can be attributed to the increasing adoption of companion animals, growing veterinary healthcare expenditure, and rising demand for animal-derived food products.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=105329994

Global Leaders:

Prominent players in the veterinary point-of-care diagnostics market include Zoetis, Inc. (US), IDEXX Laboratories, Inc. (US), Heska Corporation (US), Virbac (France), Thermo Fisher Scientific, Inc. (US), Eurolyser Diagnostica GmbH (Austria), Woodley Equipment Company (UK), Randox Laboratories LTD. (UK), AniPOC, Ltd. (UK), Carestream Health, Inc. (a part of ONEX Corporation) (Canada), NeuroLogica Corporation (a part of Samsung Electronics Co. Ltd.) (South Korea), and FUJIFILM SonoSite (a part of FUJIFILM Holdings Corporation) (Japan).